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Objectives: DETERMIND (DETERMinants of quality of life, care and costs, and 
consequences of INequalities in people with Dementia and their carers) is designed to 
address fundamental, and, as yet unanswered, questions about inequalities, outcomes and 
costs following diagnosis with dementia. These answers are needed to improve the quality of 
care and equity of access to care, and therefore the quality of life, of people with dementia 
and their carers. 
 
Method: DETERMIND is a programme of research consisting of seven complementary 
workstreams (WS) exploring various components that may result in unequal dementia care: 
WS1: Recruitment and follow-up of the DETERMIND cohort - 900 people with dementia and 
their carers from three geographically and socially diverse sites within six months following 
diagnosis, and follow them up for three years. 
WS2: Investigation of the extent of inequalities in access to dementia care 
WS3: Relationship between use and costs of services and outcomes  
WS4: Experiences of self-funders of care  
WS5: Decision-making processes for people with dementia and carers 
WS6: Effect of diagnostic stage and services on outcomes  
WS7: Theory of Change informed strategy and actions for applying the research findings 
 
Outcomes: During the life of the programme, analysing baseline results and then follow-up 
of the DETERMIND cohort over 3 years, we will establish evidence on current services and 
practice. DETERMIND will deliver novel, detailed data on inequalities in dementia care and 
what drives positive and negative outcomes and costs for people with dementia and carers, 
and identify factors that help or hinder living well with dementia. 
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What is it that enables one family to live well with dementia and another with ostensibly the 
same illness and challenges to have much poorer experiences? Which groups have better or 
worse outcomes following diagnosis of dementia and why are there inequalities in care and 
outcomes? What can we learn from the experiences of people with dementia and their 
carers to deliver care and support that maximises quality of life for all? Health and social 
care services play vital roles in sustaining the independence and quality of life of people with 
dementia and their carers1. Services may not, however, reach everyone who needs them 
due to barriers associated with availability, accessibility and acceptability[1]. Such barriers are 
likely to affect some groups more than others who, as a result, may experience unmet need, 
which in turn is known to adversely affect quality of life for people with dementia and carers[2, 
3]. Since disadvantaged groups have a higher risk of developing dementia[4], it is especially 
important to identify the extent of inequities in service access and to understand how best to 
address these (we use the term inequity to refer to an inequality that is likely to be seen as 
unfair). Existing evidence is limited in quantity and scope. Studies have found that certain 
groups of people with dementia and carers experience poorer service access, including 
those who are non-white or with lower formal education, socio-economic status or income[2, 5-
8]. However, existing studies largely focus on healthcare [6, 7, 9] and are cross-sectional[2, 5]. A 
small number of qualitative studies identify barriers to accessing dementia care, including 
poor knowledge, poor/inappropriate service provision and impact of cultural beliefs and 
previous experiences[10-12].This body of evidence is predominantly descriptive, with 
insufficient attention to understanding causes and processes[13].Public Health England, for 
example, recently recommended that “qualitative research into the differential access of 
health services by different ethnic groups mediated by different cultural beliefs is needed” 
and that “these studies should include the identification of barriers and enablers for those 
communities”[8, p.26]. 
 
In DETERMIND we will seek to go beyond a simple input-output model of dementia care 
(here is a service, people get it, and here are the outcomes) and instead unpick causal 
chains and build understanding of contextual factors. We will focus on modifiable mediating 
factors that generate unequal access and experiences, leading to inequities in outcome. 
DETERMIND therefore addresses inequalities in care provision and outcomes. DETERMIND 
focusses on the determinants of quality of life, other outcomes and costs for people with 
                                                          
1 A note on terminology: We use “carer” according to the Carers UK definition: “someone of any age providing 
unpaid support to family or friends”. “Family carer” is questioned because not all unpaid care is provided by 
families and “informal carer” because the term “informal” is seen by some carers to belittle their role. We 
acknowledge concerns with use of the term “carer” in early dementia but we have not used “supporter”, 
“carer/supporter” or “caregiver” as “carer” was preferred by our PPI group. 




dementia and their carers in the three years following diagnosis. It will investigate inequities 
and inequalities in care provision and outcomes, their causes, and their links to individual 
circumstances, including health and social care needs and strengths. It is designed to 
generate unique data that will advance social research theory and health and care practice.  
  
Aims and objectives 
Our overall aim is to explore and understand inequalities in dementia care and what drives 
good and poor quality of life, outcomes and costs for people with dementia and their carers 
following diagnosis. We will investigate how outcomes and costs vary by content and time of 
diagnosis, individual circumstances, and with varying support from health and social care 
services. To do this we have designed a programme of research with seven complementary 
workstreams (WS).  The specific aim of the seven WS are: 
 
WS1: Generate the infrastructure and data needed for DETERMIND by recruiting a new 
cohort of 900 people from three geographically and socially diverse sites with dementia and 
their carers in the six months following diagnosis, and following them up annually for three 
years. 
WS2: Provide new evidence on the extent of inequalities in access to dementia care, unmet 
need for care, barriers and facilitators to accessing care and impact of unmet need over time 
in a longitudinal context.  
WS3: Identify relationships between use and costs of services and outcomes for people with 
dementia and carers. 
WS4: Investigate the experience of people with dementia and their carers as self-funders of 
care and to compare this and their outcomes and costs with non-self-funders. 
WS5: Develop a deeper, mechanistic understanding of the processes involved in, and 
factors influencing, self-regulation and decision-making by people with dementia and carers. 
WS6: Investigate the impacts of earlier or later diagnosis and subsequent provision of 
peridiagnostic and post diagnostic treatment and care on quality of life and other outcomes 
for people with dementia and their carers.   
WS7: Co-ordinate findings from the WSs so the data generated can be translated into 
strategies and actions capable of bringing about better systems and services for people with 
dementia and carers. 
 









Overview DETERMIND will establish a bespoke cohort of people newly diagnosed with 
dementia from whom longitudinal survey and qualitative data will be gathered. We will use 
those data in seven complementary WSs designed to test specific hypotheses covering five 
of the most important information gaps in dementia care: (i) inequalities in access to care 
[WS2]; (ii) costs and outcomes and the relationship between them [WS3]; (iii) self-funding of 
social care [WS4]; (iv) decision-making [WS5]; and (v) effect of diagnosis, including 
differential effect of earlier and later diagnosis [WS6]. We will take these data and formulate 
actions to address inequalities in care in an inclusive process using Theory of Change (ToC) 
methodology in collaboration with the Alzheimer’s Society. 
 
WS1: Establishment and follow up of the DETERMIND cohort 
Research questions: WS1 generates the infrastructure within which WS2-WS6 are 
conducted. Each WS has its own detailed research questions. WS1 will be judged against 
process indicators (i.e. recruitment of 300 participants in each centre in one year, follow ups 
completed each year). 
 
Method: We will recruit, from three sites across England enrolling people from a range of 
social and economic backgrounds (South East England, South East London, North East 
England), a large (n=900) cohort of people diagnosed with dementia in the previous six 
months prior to interview. This baseline sample size will enable a difference over time 
between two subgroups in measures such as the EQ5D of 0.042 or in DEMQoL of 2.24 to be 
ascertained with power of 0.8 at 5% confidence level. This is on the basis that the annual 
attrition rate of the sample is 10% and that the subgroups are of equal size. If the attrition 
rate is 15%, a difference of 2.44 in DEMQOL could be determined (with 80% power at 5% 
significance) and if the size of the two groups is in a 3:1 ratio, a difference of 2.59 in 
DEMQOL could be established. For three groups (three pairwise comparisons), a difference 
of 3.16 in DEMQOL could be ascertained. 
 
We wish our sample to be representative of all people diagnosed with dementia so we will 
recruit without exclusion criteria. We will include people in any household situation; they will 
be primarily defined by having a diagnosis of dementia made in one of the Memory 
Assessment Services (MAS) or other services where a diagnosis of dementia may be made. 
We estimate that up to 10% may have no identifiable family or paid carer able to act as an 
informant for the carer-rated instruments, but we will include them in the cohort, subject to 
informed or proxy consent being obtained, since not having an identifiable carer may be an 
important influence on the outcomes we are studying.  





We will follow up participants annually for three years embedding qualitative work detailed in 
WS2-WS6. This allows us to look in detail retrospectively at processes leading up to 
diagnosis and the diagnostic process itself, and prospectively at outcomes and services 
used in the three years following diagnosis. Although we estimate two thirds of participants 
will have dementia of mild severity (sMMSE 20+) and a third moderate (sMMSE 10-20), we 
will not exclude people with severe dementia. We also envisage that there will be a 
substantial incidence of events of interest, with 5-15% per year entering care homes, high 
rates of transition from no-help to home care, and over half with general hospital admissions. 
Participants will be drawn primarily from MAS in the three sites chosen to enable exploration 
of key attributes in our WSs. The South East England site draws from MASs serving areas 
with high self-funding, and areas with a high south Asian older population (e.g. 
Crawley/Woking) and the oldest LGBTQ+ population in the UK (Brighton). The South East 
London site includes the inner city and sizeable older black Caribbean and south Asian 
populations, and North East England white working class and rural-dwelling older adults. 
There are important limitations to the random or population-based sampling in terms of 
yielding recruits from black, Asian and minority ethnic (BAME) groups and those from 
LGBTQ+ populations because of the relatively small numbers we will have, even with an 
overall sample size of 900. We will therefore oversample black African Caribbean and South 
Asian populations in South East England and South East London. We will aim for 25% of 
participants from these areas to be from BAME groups, yielding 150 participants for 
quantitative analyses. Although the heterogeneity within the group may be a challenge, 
when possible, we will use the multiple group approach (e.g. available in Mplus). This 
approach makes it possible to simultaneously analyse relatively small subgroups of unequal 
sample sizes. For the LGBTQ+ group, even with the concentrated population in Brighton, we 
will not have the numbers for definitive quantitative analyses; therefore we will also 
oversample this group and expect to identify 50 participants in our cohort. These numbers in 
the BAME and LGBTQ+ groups will allow us to sample purposively for the embedded 
qualitative studies, and we believe that there will be much novel, important and useful data 
on inequalities and outcomes that will come from these analyses, including areas for further 
specific investigation. 
 
Complementary recruitment strategies will be used to ensure that we are as inclusive as 
possible, particularly for those who may have been lost within the healthcare system, and 
those who were not offered opportunity to participate in the research from a healthcare 
professional. This includes the use of local ‘opt-in’ case registers at South East London[14] 
and North East England and ‘opt-out’ case registers in South East England, Join Dementia 




Research (https://www.joindementiaresearch.nihr.ac.uk/), and self-referrals via posters or 
flyers.  Following referral and consent, researchers will ask participants to complete a series 
of questionnaires that will last up to 120 minutes. The person with dementia and their carer 
(if applicable) will both complete the assessment. One option will be for these assessments 
to occur in tandem (with two researchers visiting together) and so reduce the length of time 
testing and respondent burden. Such a strategy has worked well in the MODEM study[15]. 
Participants will then be contacted annually (for three years) to arrange follow-up visits. The 
assessments will include quantitative questionnaires to assess patient quality of life, 
cognitive function, patient neuropsychiatric symptoms, carer quality of life, carer burden, use 
of services, patient activities of daily living, medication, and physical illnesses (see Table 1 
for an overview of all baseline measures). Participants will also provide consent for 
researchers to access their medical records so that we are able to ascertain further details 
about their pathways to diagnosis and subsequent health care use.  Participants have the 
option to be contacted about future research studies, and for their details to be shared with 
NHS Digital so that the research team can be notified upon their death. Qualitative 
interviews will be offered to a subset of participants, as set out in other WSs, enabling us to 
elicit a better understanding of complex issues.  
 
WS2: Inequalities in use of dementia care 
Research questions: Examining the extent and nature of inequalities will be preliminary to 
studying key questions around why some subgroups experience different access to care and 
support, what the barriers and facilitators are in the care pathways, and to generate 
grounded ideas for addressing inequities of access. We will address the following research 
questions: 
(i) How far are there inequalities of access to dementia care, including social care as 
well as health care? 
(ii) How far do these inequalities entail unmet need for care? 
(iii) Which subgroups experience unmet need and how do the unmet needs change 
over time? 
(iv) Why do inequities in access to care and consequent unmet need occur, what 
barriers and facilitators do people experience and how can groups that are 
disadvantaged in this way be best enabled to access support they need?  
(v) What are the consequences of unmet need for people with dementia and their 
carers? 
 
Method: Use of longitudinal, observational data is a powerful approach to investigate natural 
processes and what shapes them over time. Although this type of approach lacks 




experimental control over the environment, it allows studying the individual in a natural 
setting surrounded by meaningful contextual factors, which leads to a richer view of the 
interplay between the individuals and significant others and the systems around them, and 
leads to better generalizability of the findings to real-world settings. Repeated measures also 
make it possible to adjust for initial levels of needs and access, identify different patterns of 
change, and explore the interplay between changes in different processes. Such 
observational data, can usefully be further explored using qualitative methods, to allow 
investigation of underlying mechanisms and people’s first-hand perceptions and 
experiences, and to increase theoretical validity. To provide a comprehensive analysis of the 
causes and impacts of inequity in access to health and care services for people with 
dementia and their carers, as well as to identify practical and effective solutions, it is 
therefore important we explore equity of access from various perspectives using both 
quantitative and qualitative methods.  
 
In WS2, we will use a mixed methods design comprising (i) statistical analyses of existing 
datasets, (ii) statistical analyses of new DETERMIND cohort longitudinal survey data, and 
(iii) qualitative interviews of DETERMIND cohort members. We will focus on inequalities by 
ethnicity, gender, sexual orientation, marital status, socioeconomic status, and area type 
(urban/rural). In quantitative analyses, we will examine variation between groups in access 
to unpaid care provided by family and friends, to publicly and privately funded social care 
(residential and community care), and to different forms of health care. We will examine 
unmet need in terms of self-reported unmet need and self-reported disability (in particular 
activities of daily living limitations) among people not receiving care. We will consider quality 
of life using EQ-5D, DEMQOL and ONS4. There are three stages to this process. 
 
Stage 1 (months 1 to 24): We will complete secondary analyses of data from the MODEM 
study[15], the English Longitudinal Survey of Ageing (ELSA)[16], and the Cognitive Function 
and Ageing Study (CFAS)[17]. The MODEM cohort includes 300 people with dementia and 
their carers quota-sampled to balance mild, moderate and severe dementia, followed up one 
year later: it allows us to examine differences by gender and socioeconomic group in receipt 
of care and support among a mixed convenience sample of people with different dementia 
severities. ELSA analyses of waves 6-8, which contain detailed longitudinal data on needs 
and characteristics, receipt of unpaid and paid care and cognitive tests and proxy interviews 
on cognitive change (but not diagnoses of dementia) will enable us to identify, for those at 
earlier stages of cognitive decline, the level of and change in unmet needs and their 
socioeconomic correlates, and how these affect access to care and outcomes such as 
probability of entering a care home and quality of life. CFAS will allow us to explore a limited 




number of service use and demographic variables in an epidemiologically generalisable 
group of well characterised people with dementia. We will run descriptive analyses for the 
key outcomes (quality of life of people with dementia and their carers), and intermediate 
factors (unmet needs, social network, care by family and friends, publicly and privately 
funded social care including residential and community care, health care, and cost of social 
care) by cognitive functioning (ELSA) and mild, moderate and severe dementia (MODEM) 
and inequality indicators (gender, marital status, socioeconomic status and type of area 
(urban/rural). We will also examine changes over time in outcomes, intermediate factors and 
cognition/dementia. We will then analyse how the patterns of change in cognition, unmet 
needs, receipt of services and outcomes are shaped by inequality indicators using latent 
growth curves.  
 
Stage 2 (months 25 to 36): We will conduct quantitative analyses of the first wave of the new 
DETERMIND cohort data and, on the basis of the findings, develop detailed plans for stage 
three. We will first carry out descriptive analyses of the first wave on the quality of life, 
receipt of health and social care, (un)met needs and social networks by severity of dementia 
and inequality indicators. Our analyses of services received will include sources of funding 
for care including personal funds to provide key descriptive data for WS4. We will describe 
differences in receipt of health and social care between sub-groups by ethnicity, gender, 
marital status, sexuality, socioeconomic status and urban/rural area, controlling for 
differences in needs and dementia severity. We will examine to what extent identified 
subgroups receiving less care experience or perceive unmet need for care. We will then 
compare the quality of life of those experiencing unmet needs with those not experiencing 
unmet needs controlling for other factors. For these analyses, we will use multivariate 
modelling suitable for binary, ordinal and continuous outcomes, such as Generalized Linear 
Models. Latent class analysis will identify subgroups characterised by similar needs, 
strengths and service access patterns (typologies; cross-sectionally) and investigate 
potential facilitating factors associated with these patterns.  
 
Stage 3 (months 37 to 60): Through analyses of successive waves of the DETERMIND 
cohort we will examine whether inequalities in unmet need and receipt of services at 
baseline persist over time, whether unmet need at baseline and accumulation of unmet 
needs over time are associated with lower quality of life for people with dementia and their 
carers, and what processes might facilitate better outcomes over time. We will provide 
descriptions of trends in key variables from successive waves of the DETERMIND cohort for 
WS4-WS6. We will analyse how the differences in receipt of care between the different 
subgroups change over successive waves and how they are associated with differences in 




unmet need, costs of care and outcomes including quality of life. At 3-year follow-up we will 
use Latent Change Score to analyse whether the level or change in one factor affects the 
subsequent change in another factor. This is a strong method for investigating causality in 
observational studies (e.g. a facilitator improves access to care which in turn improves 
quality of life).  
 
Qualitative work: In-depth, face-to-face qualitative interviews with people with dementia and 
their carers (N=40-60) will be undertaken to examine experiences and underlying 
mechanisms, focusing on the most compelling and potentially productive questions 
emerging from quantitative analyses. These questions will be identified and refined through 
the Theory of Change workshops (WS7), with a focus on key subgroups identified in the 
quantitative research as disadvantaged in terms of their access to dementia care and 
support. To address these questions, in-depth interviews will be conducted with a 
purposively (theoretically) selected sub-sample of people with dementia and their carers. 
Our strategy, for each sub-group, will be to compare those experiencing poor access and 
unmet need and those who, despite being part of this disadvantaged sub-group, do not 
experience poor access and unmet need. This will allow us to explore not just barriers but 
also what facilitates access and protective factors. Within this, we will explore people’s 
perceptions and experiences: for example, how they perceive their need for support, 
alternative and informal sources of support, experiences of ‘help-seeking,’ and the impacts 
of unmet need. We will aim to include ‘less heard’ groups in dementia research who, even in 
our cohort, may be low in frequency, such as those who identify as LGBTQ+ and those with 
young-onset dementia. 
 
WS3: Relationship between use and cost of services and outcomes for people with 
dementia and carers 
Research questions: 
(i) How much do increases in service use lead to improvements in outcomes? 
(ii) What are the relationships between costs of care and outcomes?  
(iii) Do unmet needs have negative consequences on outcomes? 
(iv) Do the relationships between service use and outcomes vary according to 
characteristics of the person with dementia and carer? 
 
Method: Detailed data on receipt of unpaid care and use of services will be collected in WS1 
using the CSRI. Services will include primary and secondary health care, residential and 
community-based social care, special housing, aids and adaptations, technology and 
support for carers. We will estimate costs of services by applying unit costs from the latest 




PSSRU unit cost report[18] and the opportunity costs of unpaid care by applying wage rates 
for hours of personal care and national living wage for hours of other care and supervision. 
Many people in the first three years after diagnosis will have mild dementia with relatively 
little functional disability, but are likely to go from independence to service use within the life 
of the cohort. Others will develop moderate or in some cases severe dementia within three 
years of diagnosis. All will receive at least some services and most will receive unpaid care. 
It is important that services promote continued independence, offer choice, are well co-
ordinated and provide sufficient care and support to maintain good quality of life for the 
person with dementia and carers. Detailed data on outcomes for people with dementia will 
also be collected in WS1. Our main outcomes in analyses of these data will be quality of life 
for the person with dementia (DEMQOL, DEMQOL-Proxy, EQ5D, ONS4) and for carers (C-
DEMQOL, EQ5D, ONS4). For some analyses DEMQOL-Proxy, DEMQOL and EQ5D will be 
converted into QALYs using societal weights. We will also examine intermediate outcomes: 
for people with dementia these will include functional disability, social participation, 
remaining in the community (not entering residential care), and not experiencing avoidable 
hospital admission or delayed discharge from hospital; and for carers these will include carer 
stress, social participation and health. 
 
Stage 1 (months 1 to 24): We will analyse data from the MODEM study cohort of 300 people 
with dementia and their carers, in parallel with our analyses of these data in WS2. We will 
examine in particular the association between service use and costs of care in wave 1 of the 
MODEM cohort with outcomes at wave 2 and changes in outcomes between waves 1 and 2 
controlling for the needs and characteristics of the person with dementia. Findings from 
these analyses will not only provide some initial evidence and insight to answer the research 
questions but importantly will test the strategy to be used for analysing data from the new 
DETERMIND cohort.  
 
Stage 2 (months 25 to 36): We will conduct quantitative analyses of the first wave of the new 
DETERMIND cohort data and, on the basis of the findings, refine our plans for stage 3. We 
will conduct regression analyses to examine (i) the relationships at baseline between 
outcomes and service inputs and their costs; (ii) variations in this relationship by social 
determinants such as gender, marital status and socio-economic status; and (iii) the 
variation in use of services and costs between people with differing levels of cognition and 
functional disability, controlling for individual characteristics.  
 
Stage 3 (months 37 to 60): We will examine how care packages and their costs at 
successive waves of the cohort are associated with outcomes at different points in time 




(RQs 1 and 2) and how this relationship varies with the personal characteristics of the 
person with dementia and carer (RQ4). We will study how unmet needs in earlier waves 
affect outcomes in later waves (RQ3) and how this relationship varies with the 
characteristics of the person with dementia and carer (RQ4). Longitudinal analyses will 
examine influences on outcomes at different time-points. 
 
Statistical methods: In all stages, we will first conduct descriptive analyses to investigate the 
characteristics of people in the sample and understand how different variables are 
correlated. To understand the relationships between outcome and costs, in stages 1 and 2, 
we plan to build linear regression models. The dependent variables will be the quality of life 
of older people living with dementia and the immediate outcomes outlined above. The key 
independent variables are the use of care services, unmet needs and costs of care.  
 
Drawing on the rich information in the MODEM (see WS2) and DETERMIND datasets, we 
will control for demographic characteristics (age, gender, ethnicity), social support network 
(marital status, living arrangements, number of children), care needs and strengths (severity 
of dementia, self-reported health, and number of chronic diseases), and socioeconomic 
status (income, education, and housing tenure). We will calculate robust standard errors to 
take account of the heteroskedastic data and make valid statistical inferences. We will 
conduct post-estimation diagnostics to make sure that our models are correctly specified and 
to minimise any bias in our estimates. In stage 3, we will build multi-level linear regression 
models and latent growth curve models. Drawing on a longitudinal dataset, a multilevel 
design has two further advantages. First, it accounts for the unobserved individual-level 
heterogeneity which may lead to biased regression results. Second, by including a time 
variable, random intercept and random slope (coefficient) in the models allows us to 
examine trajectories of quality of life and immediate outcomes over time and so understand 
better the important factors that alter these trajectories. 
 
WS4: Experience of self-funders of care 
Research questions:  
(i) What are self-funders’ experiences of navigating care systems and arranging care 
post-dementia diagnosis? 
(ii) What are the patterns of self-funders’ journeys over time, and how do these differ 
from those of people funded by councils? 
(iii) How do interactions with key people and services affect self-funders’ choices and 
decision-making over time? 




(iv) What are the socio-demographic characteristics of self-funders, and what role do 
particular characteristics such as age, sexuality and ethnicity play in decision-making and 
experiences of care and support? 
(v) What social science theories facilitate understanding of self-funders’ experiences? 
 
Method: WS4 will investigate the experiences of people with dementia and carers who are 
presented with the challenges and opportunities of self-funding. We will initially identify, 
using economic characteristics, those in our DETERMIND cohort who are likely to become 
self- or council-funded (WS1), and follow them up to explore differences in costs and 
outcomes quantitatively, the decisions that they make, when they make them and the 
relationship with subsequent transitions in care. We will examine difference in patterns 
between self- and council-funded individuals (e.g. falling back on council funding when 
personal resources are depleted). We will identify those starting home care and making 
transitions into care homes, exploring these processes in detail through in-depth qualitative 
interviews with people with dementia and their carers. Interviews will also explore 
interactions with service providers, councils, family, friends and carers, and sources of 
information such as the internet, plus experiences of choice and control, especially at key 
transitions between services or sectors. WS4 will yield valuable data via complementary 
quantitative and qualitative approaches interfacing with WS5 developments on individual 
characteristics that determine choice and effective use of that choice and WS6 in the effects 
of services over time.  
 
Through semi-structured interviews we will explore experiences and issues of information-
need and seeking, reassurance and confidence in decision-making as well as the dynamic 
journey through the condition in relation to care and funding for self-funders living with 
dementia. The topic guide will ensure consistency, but the format will be flexible to allow 
participants to generate naturalistic data on what they constitute as important and/or 
successful in terms of outcomes. It is anticipated that an initial sample of 30 people with 
dementia and/or their carers will be selected from baseline data, with 10 followed up at two 
time points (12m and 24m). A further 20 selected from discussions with other work streams 
to target arising points for further exploration will be selected from 12 month follow up data 
and followed up (at 24m and 36m). Sampling will be driven from two perspectives: (i) 
purposive sampling to achieve maximum variation addressing gender, ethnicity, living 
circumstances, funding, levels of care need, impact of dementia; and (ii) to further explore 
questions informed by interim analyses emerging from the cohort data. 
 
WS5: Understanding decision-making by people with dementia and carers 




The principal research question addressed by WS5 is: 
Do individual differences in self-regulation predict differences in outcomes (e.g., 
decision-making, quality of life, well-being) over time?  
 
Method: The basic assumption underlying analyses in WS5 is that individuals’ self-
regulatory and decision-making competencies following a diagnosis of dementia vary, and 
thus different people will show different response trajectories, and benefit from different 
support. Consistent with the notion of precision medicine, the ultimate goal is to understand 
how best to support decision-making for the best personal outcome, optimally using the 
resources available. We will first explore how differences in key elements related to decision-
making competencies (understood through core aspects of self-regulation: emotion 
regulation, cognitive control, self-reflection) impact upon various outcomes such as well-
being and quality of life and how this changes with disease progression. We will examine 
how standardized measures of the core aspects of self-regulation (e.g., emotion regulation: 
mDES, ERQ; cognitive control: Brief COPE; self-reflection: SSAM, LOT, BPNSF) individually 
and jointly determine indicators of decision making (e.g., CFQ, BADL, DMI, responses to 
specific decision-making questions embedded in Brief COPE, SOC, and BPNSF) and how 
this can help us to understand individual differences in outcomes (linking with WS3). 
Disease progression, indexed by sMMSE, NPI, and IES will be included in the model.  
 
Quantitative analyses will include examining cross-sectional and longitudinal associations 
between variables. These will be supplemented by the use of purposively sampled 
qualitative interviews with individuals whose trajectories diverged at key decisions to 
enhance our understanding of decision making processes and their impact on outcomes. For 
WS5, a key focus will be on the role of emotion regulation, an important but poorly 
understood predictor of outcomes in both people with dementia and carers[19, 20]. The 
combined insights from qualitative and quantitative data will allow us to develop grounded 
hypotheses to inform the development of mechanistic models of decision making and to 
move towards the development of empirically grounded behavioural interventions.   
 
WS6: Effect of diagnostic stage and services on outcomes 
Research questions: 
(i) How do outcomes for people with dementia and their carers vary by diagnosis at 
earlier/later stages of the disorder?  
(ii) What diagnostic service characteristics predict better and worse outcomes? 
(iii) How do outcomes for people with dementia and carers vary by differing 
peridiagnostic and post-diagnostic care?   





Method: The interviews will include at baseline a direct assessment of severity of dementia 
at diagnosis from MAS notes, MMSE score and Clinical Dementia Rating (CDR), a four-point 
global staging of dementia (0.5=minimal, 1=mild, 2=moderate, 3=severe). We will define 
‘earlier’ as CDR=0.5&1 and ‘later’ as CDR=2&3 at diagnosis. We will also at baseline 
ascertain the date of onset (6m period) of first symptoms of dementia and date and pathway 
to diagnosis including a retrospective assessment of service receipt up to diagnosis, so 
allowing an assessment of time to diagnosis from emergence of the dementia. Illness 
trajectory to diagnosis will be ascertained by time from first symptoms to diagnosis and CDR 
stage at diagnosis. We will prospectively record the offers and use of post diagnostic health 
and social care services over the three year follow up period.  
 
Quantitative analyses will focus on assessing the impact of earlier/later diagnosis of 
dementia, service characteristics, and subsequent care on outcomes, identifying predictors 
of good/bad outcomes. For example, in the earlier/later stage diagnosis analyses, adjusting 
for patient characteristics, the specific hypotheses to be tested will include whether there are 
clinically significant differences between those diagnosed earlier compared with later at 
12/24/36m in: (i) person with dementia HRQL (DEMQOL/DEMQOL-Proxy) higher by 4 
points; (ii) comprehensive costs (CSRI) lower; (iii) emotional impact of diagnosis (IES) lower; 
(iv) carer burden (CBI) lower; (v) carer quality of life (EQ-5D and C-DEMQOL) higher. In the 
first stage of the analyses, descriptive statistics will characterise the samples at baseline. 
Our primary analysis will be a multiple linear regression model with DEMQOL-Proxy as 
outcome, baseline DEMQOL-Proxy as covariate, and stage at diagnosis as our main 
covariate. We will adjust for other possible confounders at baseline. We will use similar 
models for secondary outcomes. Stage will be defined primarily as a binary variable (CDR 
earlier=0.5&1, later=2&3) in secondary analyses this will be examined as an ordered 
categorical variable (0.5/1/2/3). The final analysis will model all outcomes (12/24/36m) in a 
mixed effects model using the same covariates. DEMQOL-Proxy is our primary outcome, 
dementia is progressive and DEMQOL-Proxy has good psychometric properties across the 
range of dementia severity.  
 
To complement and contextualise the quantitative data we will complete in-depth interviews 
with people with dementia and carers from the cohort to capture different narratives of ‘how’ 
and ‘why’ things happen at diagnosis and after, and how these affect quality of life and other 
outcomes. These interviews will provide an understanding of the impacts and outcomes of 
diagnosis on patients and carers over time. Specifically, they enable us to explore how 
variation by earlier or later diagnosis and post-diagnostic care, including how services and 




the diagnostic process are perceived, enhance or impair quality of life. These interviews will 
explore post-diagnosis expectations and experiences that endure, what changes and what, 
over time, ceases to be an issue. A maximum variation sample will be drawn to ensure 
inclusion of key characteristics (e.g. ethnicity, living alone) to aid generalisability. Interview 
guides will be developed with the research team from the literature[21, 22] and our PPI panel. 
The framework for interviews and analysis will draw on stress, appraisal and coping 
theory[23]. Based on earlier work we anticipate three broad areas that are likely to be affected 
by when and how they received their dementia diagnosis: (i) how it affects individuals’ sense 
of self, relationships and ability to maintain activities that are important to them as active 
citizens; (ii) how it enables them (or not) to adapt and use technologies and existing 
networks of support; and (iii) how it links to the use of information and the ability to connect 
with and navigate professional systems of support. We will triangulate the complementary 
quantitative and qualitative data to generate an evidenced framework to help professionals 
understand better the positive/negative impacts of making a diagnosis in dementia at 
differing stages. 
 
WS7: Programme management and Theory of Change guided research development, 
coordination and promotion of impact  
We will use Theory of Change to coordinate and co-develop research findings from each of 
the WSs in order to generate a theoretically integrated and holistic model of inequities in 
dementia care. This model will, in turn, help guide our outputs and proposed actions for 
impact. The development of the theory of change model will be both iterative and 
collaborative, extending over the course of the project and undertaken in close collaboration 
with stakeholders, including people with dementia, carers, practitioners, commissioners and 
policy makers. Theory of change is particularly well suited to guiding investigations into 
mediating factors in complex systems. The theory of change model will also provide a visual 
conceptual map of the journey undertaken by people with dementia and carers, covering 
initial diagnosis, post-diagnostic care and outcomes of interest, and will clarify how mediating 
factors explored in WS2-WS6 shape people’s experiences, access to support and the 
outcomes they achieve. Led as a separate WS, we will use this theory-driven framework in 
four key ways:  
 
(i) To coordinate and integrate research processes 
(ii) To facilitate the conceptually-grounded integration of findings 
(iii) To facilitate and capture practice insights from stakeholders 
(iv) To guide and support stakeholder engagement approaches, communication, 
influencing and co-production strategies 






Phase 1 (months 3 to 9): We will organise two initial theory of change workshops; each will 
introduce, develop and refine an initial theory of change model to establish a clear, shared 
starting point. One of these workshops, for the research teams, will be used to clarify 
relevant theoretical and conceptual frameworks (relevant to the overall model and/or specific 
aspects of it) and to represent these appropriately (as, if necessary, provisionally) in the 
model, making clear how they inform research questions, hypotheses, assumptions and/or 
interpretive frameworks. Research questions and approaches will be honed in light of these 
discussions and clear objectives for each WS will be established. For our second workshop, 
we will identify key national stakeholders, with the help of our academic partners, 
Alzheimer’s Society and other health and care partners. We will share the evolving theory of 
change model and seek input and insights to inform it as a whole and to help develop ideas 
within specific WSs. We will also use these discussions to begin to identify contextually 
feasible goals, outputs and pathways to effect necessary changes in practice. In addition to 
the workshops, we will conduct six face-to-face qualitative interviews with senior staff from 
local service providers in the areas that our cohort is drawn from to provide the project team 
with further relevant context; the content of these interviews will be determined during the 
workshops.  
 
Phase 2 (months 18, 30 & 42): We will reconvene our researcher and stakeholder groups 
annually over the next 3 years to develop the overall theory of change model. In these 
workshops, we will review data and findings to date, clarify how these shape the model and, 
as needed, further refine and focus the investigations in each WS. We will also use the 
workshops to review progress using indicators developed as part of the theory of change 
process, for each WS and the programme as a whole. In the workshop held 18 months into 
the project, for example, we will review the recruitment of the cohort to target and its 
characteristics (WS1); and review emerging data from analyses of ELSA, MODEM and 
CFAS to inform the next stage analyses of the DETERMIND cohort (WS2, WS3).  
 
Phase 3 (months 54 to 60): In two further sets of workshops, we will intensively refine and 
finalise the overall theory of change model so that it adequately reflects findings from each 
WS, provides an overall conceptual map of ways in which mediating factors influence 
access, experiences, outcomes and costs and, within this, develop and refine practical 
proposals for addressing inequities. These proposals will be grounded in empirical, 
conceptual and theoretical developments and be located clearly within causal pathways. In 
addition to working with experts, advisors, people with dementia and carers in workshops we 




will also conduct nine interviews with senior staff from service providers in the areas from 
which the cohort is drawn to gain additional insights into the model and to 'road-test' ideas 
and proposals generated through the theory of change workshop process. Through these 
activities we will agree the final set of conclusions, recommendations and actions. 
 
DETERMIND PPI and ethical processes 
PPI process: Margaret Dangoor (MD), an expert by experience of being a family carer for 
two people with dementia over a 20-year period and is active in the dementia and carer 
community, is a full applicant on this proposal and has been involved in all stages of the 
research. The Alzheimer’s Society supports this programme and has agreed to work with us 
as an integral element of our PPI strategy and in WS7 throughout the programme. Pre-study 
PPI consultation identified sensitivities for carers, reflecting on different experiences of 
diagnosis and post-diagnostic support. Group members identified the need for interviewers 
to be aware of and trained for the emotional impact of interviews. The group reinforced the 
need to ensure that recruitment represents a diverse population.  
 
Our PPI lead MD has set up a Reference Group of Users and Carers (RGUC) of about ten 
people, and as noted above, has been involved in all stages of the preparation of our 
proposal. The RGUC, which will be an evolving group and aim to reflect the diversity of 
people with dementia and their carers, will meet at least twice in the first year, and then at 
key points in the project when we are facing key decisions about next steps or about the 
interpretation of findings. Some members will be asked to join project subgroups. The RGUC 
will be represented on the project’s Advisory Group. The RGUC will meet throughout the 
study: prior to ethics submission they will consult on consent and information sheets; they 
will represent the patient/carer view in recruitment preparation; troubleshoot recruitment 
issues; collaborate in the development of frameworks for interviews in the qualitative 
elements of the study; and support the interpretation of results and dissemination to patient 
and carer groups. Deliberative workshops will inform interpretation and dissemination of 
findings.  
 
Ethical considerations: Ethical approval for the study has been obtained from The London: 
Brighton and Sussex Research Ethics Committee (REC 19/LO/0528). Where possible, fully 
informed written consent will be obtained from people with dementia at entry, carers will give 
their consent for their own participation. Some people with dementia may lack the mental 
capacity to give this. The study aims are incompatible with only entering people with mild 
dementia and capacity. Also we must allow for increasing severity of dementia over time with 
possible loss of capacity. After the study has been explained and information given, all 




people with dementia will have capacity assessed by a trained researcher. Agreement to 
participate will be obtained to their best level of understanding and recruitment will not 
proceed if they refuse or show signs of distress. Each participant with dementia, will have a 
consultee (personal or professional) identified. Where capacity is lacking, their opinion will 
be sought about whether the person with dementia would have chosen to participate if they 
still had capacity to express a view. They will be asked to sign a consultee declaration. 
Those assessed as not having the capacity to consent will be enrolled if they show no 
objection to participation. If the participant loses capacity (assessed each visit) their 
consultee will be asked to make decisions on their behalf. 
 
Conclusion 
This is a mixed methods study with integrated and complementary quantitative and 
qualitative enquiry that seeks to examine and address inequalities in dementia care. The 
new DETERMIND cohort will facilitate regularly collected quantitative data across the 
pathway of the journey through dementia from diagnosis. This will be combined with 
qualitative methods to allow in-depth enquiry at regular points, providing the opportunity to 
systematically interrogate trends from the quantitative data and to generate new hypotheses 
and insights. We will use ‘triangulation protocols’ at a thematic level and ‘mixed methods 
matrices’ at the level of individual cases for data integration. 
 
Next steps: It is a major strength of DETERMIND that we can look in detail at the first three 
years following diagnosis. It is a weakness that much will happen in the next five years after 
this study has finished its follow-up. Once we have recruited our cohort we will seek further 
funding to complete five additional waves of follow-up from four to eight years following 
diagnosis. This would be a very valuable extension 
 
Data availability 
Direct access will be granted to authorised representatives from the Sponsor and host 
institution for monitoring and/or audit of the study to ensure compliance with regulations. All 
research data will be archived and securely stored for 10 years after the end point of the 
study. Following the end of the study, anonymised data will also be uploaded to the UK Data 
Archive online repository. Access to data will be limited to authorised researchers who will 
agree to the End User License (http://dataarchive.ac.uk/conditions). 
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Table 1: Baseline Measures for DETERMIND 
Measure Description Ref 
Assessment Toolkit for Dementia 
with Lewy Bodies 
A 15 item toolkit that aims to facilitate a diagnosis of 
dementia with Lewy bodies 
[24] 
Basic Psychological Need 
Satisfaction and Frustration Scale 
(BPNSF) 
A 24 item questionnaire to measure addresses both 
need satisfaction and frustration in general in one's 
life 
[25] 
Brief COPE A 28-item measure of coping with life stressors. [26] 
Bristol Activities of Daily Living 
(BADL) 
A 20-item question of activities of daily living [27] 
Charlson Comorbidity Index (CCI) A 16-item checklist of common comorbidities [28] 
Cognitive Failures Questionnaire 
(CFQ) 
25 items to assess the frequency people experience 
cognitive failures 
[29] 
Clinical Dementia Rating Scale 
(CDR) 
A brief measure of dementia severity [30] 
Client Service Receipt Inventory 
(CSRI) 
A well-established instrument for the assessment of 
direct and indirect costs of illness. The measure 
includes participant demographics, support provided 
and care planning 
[31] 
Decision-Making Involvement Scale 
(DMI) 
15 item scale providing a direct measure of a person 
with dementia’s reported engagement in the 
decision-making process 
[32] 
C-DEMQOL A 30-item questionnaire to assess quality of life in 
family carers of people with dementia 
[33] 
DEMQOL 28 item interviewer-administered questionnaire 
answered by the individual with dementia, dementia 
specific health related quality of life measure 
[34] 
DEMQOL-Proxy 31 item interviewer-administered questionnaire 
answered by the caregiver on the individual with 
dementia, dementia specific health related quality of 
life measure 
[34] 
Emotion Regulation of Others and 
Self extrinsic subscale (EROS) 
A 9-item questionnaire individual differences in the 
use of strategies to improve and to  worsen one’s 
own and other people’s affect 
[35] 




EuroQol (EQ5D-5L) A 5 item, self-report questionnaire on generic health 
related quality of life 
[36] 
IDEAL study questionnaire A self-created questionnaire on planning for the 
future and the relationship between the person with 
dementia and carer 
 
Impact of Event Scale-Revised (IES-
R) 
22-item questionnaire that quantified the frequency 
of intrusive thoughts and avoidance behaviors 
associated with stressful events. The scale has been 
adapted to specifically relate to the diagnosis of 
dementia. 
[37] 
Life Orientation Test-Revised 
(LOTR) 
A 10- item measure of optimism vs pessimism [38] 
Lubben Social Networks Scale A 6-item version to assess social engagement. [39] 
Modified Differential Emotions 
Scale (mDES) 
A 20-item measure of discrete emotions, both 
positive and negative 
[40] 
Multiple Group Memberships Scale 
(MGM) 
A 4-item scale measuring subjective multiple group 
memberships. 
[41] 
Neuropsychiatric Inventory (NPI) Brief rating scale to record presence of behavioural 
and psychiatric symptoms in dementia 
[42] 
ONS4 A four item questionnaire of personal well-being [43] 
Selection, Optimization and 
Compensation scale (SOC) 
A 12-item questionnaire to assess selection, 
optimization and compensation 
[44] 
Single Item Self-esteem Scale A single item measure of self-esteem [45] 
Spontaneous self-affirmation 
measure (SSAM) 
A 10-item measure of self-affirmation [46] 
Standardized Mini-Mental State 
Examination (sMMSE) 
A brief, global measure of cognitive function [47] 
Trail Making Task (TMT) A neuropsychological test to measure executive 
function, visual attention, task switching and 
inhibition.   
[48] 
Zarit Carer Burden Inventory – 
Short Form (ZCBI) 
A 12 item scale to measure carer burden [49] 
 
